| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||
Net Loss | |||||||||
-10,587 | -15,676 | -7,104 | -6,345 | -4,318 | -3,654 | -4,587 | -4,057 | -5,869 | -7,563 |
Adjustments to reconcile net loss from operations to net cash used in operating activities: | |||||||||
Stock-based compensation | |||||||||
822 | 2,379 | 1,193 | 1,984 | 1,881 | 282 | 329 | 975 | 1,513 | 2,691 |
Write off of deferred financing costs | |||||||||
- | 982 | - | - | - | - | - | - | - | - |
Amortization of deferred financing cost | |||||||||
- | - | 491 | 191 | 0 | - | - | - | - | - |
Equity in loss from joint venture | |||||||||
-3,321 | -5,835 | - | - | - | - | - | - | - | - |
Abandonment loss | |||||||||
- | - | 37 | 0 | 433 | - | - | - | - | - |
Abandonment loss | |||||||||
- | - | - | - | - | 0 | - | - | - | - |
Depreciation and amortization | |||||||||
- | - | - | - | - | - | 17 | 28 | 26 | 27 |
Loss on marketable securities | |||||||||
- | - | - | - | - | -1 | -49 | 195 | 93 | -116 |
Warrant revaluation | |||||||||
- | - | - | 1,672 | 2,306 | 1,162 | 277 | - | - | - |
Warrant modification expense | |||||||||
- | - | - | 162 | 0 | - | - | - | - | - |
Implied interest expense on deferred lease abandonment liability | |||||||||
- | - | 16 | 26 | 0 | - | - | - | - | - |
Changes in operating working capital items: | |||||||||
Accounts receivable - fees and reimbursable project costs | |||||||||
- | 10 | 378 | 248 | -329 | 43 | -175 | 324 | -713 | -1,430 |
Other receivable from joint venture | |||||||||
-306 | -93 | - | - | - | - | - | - | - | - |
Prepaid expenses and other current assets | |||||||||
-10 | 33 | - | - | - | - | - | - | - | - |
Accounts payable and accrued liabilities | |||||||||
92 | -893 | - | - | - | - | - | - | - | - |
Prepaid expenses and other current assets | |||||||||
- | - | 10 | -87 | -37 | -83 | -285 | 184 | -95 | -208 |
Accounts payable and accrued liabilities | |||||||||
- | - | 159 | 101 | 292 | 177 | 91 | -1,295 | -337 | 629 |
Deferred lease abandonment liability | |||||||||
- | - | -185 | 263 | 0 | - | - | - | - | - |
Deferred revenue | |||||||||
- | - | - | - | - | - | - | - | -98 | 98 |
Net Cash Used In Operating Activities | |||||||||
-6,667 | -7,421 | -5,003 | -5,976 | -3,650 | -4,315 | -3,916 | -5,053 | -4,050 | -2,361 |
Investing Activities: | |||||||||
Investment in joint venture | |||||||||
-3,540 | -5,617 | - | - | - | - | - | - | - | - |
Patent costs | |||||||||
-221 | -209 | - | - | - | - | - | - | - | - |
Proceeds from the sale of marketable securities | |||||||||
- | - | - | - | - | 14 | 1,572 | 3,979 | 10,408 | 0 |
Purchase of marketable securities | |||||||||
- | - | - | - | - | - | 38 | 234 | 5,000 | 10,577 |
Purchase of property and equipment | |||||||||
- | - | - | - | - | - | - | - | - | 1 |
Patent costs | |||||||||
- | - | 207 | 209 | 117 | 134 | 98 | 63 | 159 | 135 |
Property and equipment | |||||||||
- | - | - | - | - | - | - | -0 | 1 | - |
Net Cash Used In Investing Activities | |||||||||
-3,761 | -5,826 | -207 | -209 | -117 | -119 | 1,434 | 3,681 | 5,247 | -10,714 |
Financing Activities: | |||||||||
Net proceeds from the issuance of common stock | |||||||||
3,750 | 29,469 | 6,027 | 6,135 | 171 | 4,753 | 3,958 | 1 | 0 | 12,562 |
Net proceeds from the issuance of preferred stock | |||||||||
- | 3,900 | - | 2,800 | 0 | - | - | - | - | - |
Proceeds from the issuance of note payable | |||||||||
- | - | - | 135 | 0 | - | - | - | - | - |
Repayment of note payable | |||||||||
- | - | - | 135 | 0 | - | - | - | - | - |
Redemption of common stock into treasury stock | |||||||||
- | - | - | - | - | - | - | - | - | 243 |
Restricted cash | |||||||||
- | - | -114 | -211 | 0 | -229 | 1 | 1 | 1 | -101 |
Net Cash Provided by Financing Activities | |||||||||
3,750 | 33,369 | 6,141 | 9,147 | 170 | 4,983 | 3,956 | -0 | -1 | 12,420 |
Net Decrease In Cash and Cash Equivalents | |||||||||
-6,678 | 20,121 | 930 | 2,961 | -3,597 | 547 | 1,475 | -1,371 | 1,195 | -655 |
Cash paid during the year | |||||||||
Interest paid | |||||||||
- | - | - | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Income taxes paid | |||||||||
- | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Non-Cash Financing Activities: | |||||||||
Deemed dividend on issuance Series B convertible preferred stock due to beneficial conversion feature | |||||||||
- | 2,624 | - | - | - | - | - | - | - | - |
Deferred financing costs | |||||||||
- | - | - | 1,664 | 0 | - | - | - | - | - |
Warrant liability - reclassification to equity | |||||||||
- | - | - | 817 | 0 | - | - | - | - | - |
Deemed dividend on convertible preferred stock, due to beneficial conversion feature | |||||||||
- | - | - | 581 | 0 | - | - | - | - | - |
Accumulated preferred stock dividend | |||||||||
699 | 649 | 276 | 80 | 0 | - | - | - | - | - |
Conversion of Series A convertible preferred stock to common stock and payment of paid-in-kind dividends to Series A preferred stockholder | |||||||||
187 | 206 | - | - | - | - | - | - | - | - |
Decrease in accrued liabilities - stock-based compensation | |||||||||
- | - | 121 | 0 | - | - | - | - | - | - |
Warrant liability - fair value of warrants exercised | |||||||||
- | - | - | - | - | 331 | 0 | - | - | - |
Retirement of Treasury Stock | |||||||||
- | - | - | - | - | - | - | - | - | 243 |
Grant of Common Stock for Payment of Accrued Liabilities | |||||||||
- | - | - | - | - | - | - | - | 70 | 703 |